Glioma

The experimental cancer vaccine SurVaxM may improve survival in people with newly diagnosed glioblastoma, an aggressive form of glioma. The therapy’s developer, Mimivax,…

The experimental immunotherapy IGV-001 may improve survival outcomes in certain people with an aggressive form of glioma called glioblastoma (GBM), according to a new…

A CAR T-cell therapy targeting glioblastoma improved tumor control and survival in mice when given before surgery rather than afterward, according to a new study.

Safusidenib, an experimental oral treatment for people with gliomas carrying IDH1 gene mutations, has received fast-track designation from…

Treatments using gamma delta T-cells, a type of immune cell, hold promise for treating glioblastoma, scientists said, though they added that much more research is…

July 15 marks the eighth annual Glioblastoma Awareness Day in the U.S., and advocates are calling for continued efforts to advance research and improve life…

A new arm of a clinical trial has begun testing Knoa Pharma‘s experimental therapy tinostamustine in people with glioblastoma, an aggressive form of…

Starting the electrical therapy Optune Gio during radiation therapy and chemotherapy, rather than after it as indicated, did not extend survival in people with newly…

NeuExcell Therapeutics‘ investigational gene therapy, NXL-004, showed a potential survival benefit in a small group of people with recurrent malignant glioma in an…

Preliminary Phase 1 trial data show that uTREAT, Curasight’s experimental targeted cancer therapy, was safely delivered to aggressive solid brain tumors and reached estimated…